Bayer stock at EUR 54.12, slips 0.22% before Xetra open
Published on 11/05/2026 at 08:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBayer balances health and food businesses
- Bayer operates across Crop Science, Pharmaceuticals and Consumer Health.
- The company lists third-quarter 2026 results among its investor materials.
- Pharmaceuticals and crop solutions remain central to Bayer's investment case.
Bayer stock slipped before the Xetra opening on Thursday, November 5, 2026, as the healthcare and agriculture group entered the session below the previous Xetra close.
Bayer stock traded at EUR 54.12 on Lang & Schwarz at 08:25 CET on Thursday, November 5, 2026, 0.22 percent below the Xetra close of Wednesday, November 4, at EUR 54.24; the real-time quote of Bayer stock is available here.
Business mix remains broadly diversified
According to Bayer Investor Relations, the group serves essential healthcare and food needs through Crop Science, Pharmaceuticals and Consumer Health. The investor-relations page lists third-quarter 2026 results and highlights innovation pipelines and market opportunities in its investment case.
The combination gives investors exposure to prescription medicines, consumer products and agricultural solutions. At the same time, the different businesses can respond differently to pricing, research milestones, crop conditions and regulatory decisions, making segment performance important for the share outlook.
European equities will set the broader market backdrop ahead of the Xetra session; follow the DAX market overview for the regional context.
Further updates are available in More news and analyses on Bayer stock.
